Literature DB >> 3291457

Protective and autoimmune epitopes of streptococcal M proteins.

E H Beachey1, M Bronze, J B Dale, W Kraus, T Poirier, S Sargent.   

Abstract

Several rheumatogenic serotypes of streptococcal M protein have been shown to contain both protective and cardiac tissue crossreactive epitopes. By synthesizing peptides copying different regions of M protein polypeptides, we were able to localize the protective and heart crossreactive epitopes. Some epitopes are only opsonic, some are only crossreactive, whereas others are both opsonic and tissue crossreactive. Multivalency of vaccines can be obtained by synthesizing protective peptides of one M serotype in tandem with protective peptides of other M serotypes. Such hybrid peptides evoke protective immune responses against the related streptococci without evoking tissue crossreactive immunity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3291457     DOI: 10.1016/s0264-410x(88)80027-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

Authors:  Mary A Hall; Steven D Stroop; Mary C Hu; Michael A Walls; Mark A Reddish; David S Burt; George H Lowell; James B Dale
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  The prospect of vaccination against group A beta-hemolytic streptococci.

Authors:  Karen L Kotloff
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

3.  Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.

Authors:  H Basma; A Norrby-Teglund; A McGeer; D E Low; O El-Ahmedy; J B Dale; B Schwartz; M Kotb
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients.

Authors:  M El-Demellawy; R El-Ridi; N I Guirguis; M Abdel Alim; A Kotby; M Kotb
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study.

Authors:  K F Jones; S S Whitehead; M W Cunningham; V A Fischetti
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 6.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

7.  Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease.

Authors:  Davina Gorton; Suchandan Sikder; Natasha L Williams; Lisa Chilton; Catherine M Rush; Brenda L Govan; Madeleine W Cunningham; Natkunam Ketheesan
Journal:  Autoimmunity       Date:  2016-08-25       Impact factor: 2.815

8.  B- and T-cell responses in group a streptococcus M-protein- or Peptide-induced experimental carditis.

Authors:  Davina Gorton; Brenda Govan; Colleen Olive; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

9.  Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

Authors:  Harry S Courtney; David L Hasty; James B Dale
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Characterization of a conserved helper-T-cell epitope from group A Streptococcal M proteins.

Authors:  J H Robinson; M C Case; M A Kehoe
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.